A Pseudo-Right Atrial Mass in Massive Pulmonary Embolism: A Case Report Highlighting Multimodality Imaging and Multidisciplinary Team Review
- PMID: 41487747
- PMCID: PMC12757089
- DOI: 10.7759/cureus.98329
A Pseudo-Right Atrial Mass in Massive Pulmonary Embolism: A Case Report Highlighting Multimodality Imaging and Multidisciplinary Team Review
Abstract
Transthoracic echocardiography (TTE) is often the first-line imaging modality in cardiac assessment due to its accessibility and rapid acquisition. However, compared with cardiac magnetic resonance (CMR), it offers limited tissue characterisation and may misinterpret anatomical variants as pathology. Consequently, multimodality imaging and multidisciplinary team (MDT) review are frequently required for accurate diagnosis. A 44-year-old man presented with acute dyspnoea following long-haul travel. Computerised tomography pulmonary angiography revealed massive bilateral pulmonary emboli without right ventricular strain, and he was treated with rivaroxaban 20 mg once a day. Three months later, follow-up TTE demonstrated a right atrial mass, reported as a possible thrombus, prompting anticoagulation change to warfarin. At six months, CMR showed no intracardiac mass. However, repeat TTE at one year again suggested a right atrial mass. A review during the cardiac imaging MDT concluded that the apparent "mass" represented epicardial fat entering the imaging plane. Rivaroxaban 20 mg once a day was reinstated for indefinite anticoagulation. This diagnostic pitfall led to an unnecessary switch to warfarin, highlighting how misinterpretation of anatomical variants can significantly alter clinical management. This case underscores the critical role of multimodality imaging and MDT review in the evaluation of intracardiac masses to prevent misdiagnosis and unnecessary treatment.
Keywords: direct oral anticoagulant therapy; mri cardiac; multidisciplinary teams; right atrial cardiac mass; transthoracic echocardiogram.
Copyright © 2025, Gupta et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. Kirkpatrick JN, Wong T, Bednarz JE, et al. https://pubmed.ncbi.nlm.nih.gov/15093876/ J Am Coll Cardiol. 2004;43:1412–1419. - PubMed
-
- Cardiovascular magnetic resonance of cardiac tumors and masses. Gatti M, D’Angelo T, Muscogiuri G, et al. https://pmc.ncbi.nlm.nih.gov/articles/PMC8641001/ World J Cardiol. 2021;13:628–649. - PMC - PubMed
-
- Cardiac masses and tumours. Basso C, Rizzo S, Valente M, Thiene G. https://pubmed.ncbi.nlm.nih.gov/27277840/ Heart. 2016;102:1230–1245. - PubMed
-
- Cardiac tumors: JACC CardioOncology state-of-the-art review. Tyebally S, Chen D, Bhattacharyya S, et al. https://pubmed.ncbi.nlm.nih.gov/34396236/ JACC CardioOncol. 2020;2:293–311. - PMC - PubMed
-
- Cardiac tumors prevalence and mortality: a systematic review and meta-analysis. Rahouma M, Arisha MJ, Elmously A, et al. https://pubmed.ncbi.nlm.nih.gov/32169566/ Int J Surg. 2020;76:178–189. - PubMed
Publication types
LinkOut - more resources
Full Text Sources